More

    Cancer cured, did scientists discover a cure for this disease? 

    Now the cancer is going to be cured. Medical science has tested a drug that can help patients get rid of cancer. Early trials for the treatment of rectal cancer have been successful. Only 18 patients who participated in the test have been cured of cancer.

    According to a report in the New York Times, in a small clinical trial, 18 patients had used a drug called dosterlimab for about six months, after which they found that the tumor had disappeared.

    A drug containing molecules manufactured by Dostarlimab Laboratory acts as a substitute antibody in the human body. The same medicine was given to 18 patients with rectal cancer. As a measure of treatment, cancer has been completely eradicated in all patients. Other tests, such as endoscopy, MRI scan and positron emission tomography, did not show any cancer.

    Dr. of Memorial Sloan Kettering Cancer Center in New York. Lewis A. Diaz Jale says this is the first time in the history of cancer. During the test, it was revealed that the patients had taken the medicine every three weeks for six months. All of these patients had the same type of cancer in the rectum but did not spread.

    According to the New York Times, other patients in clinical trials so far have had to undergo chemotherapy, radiation and invasive surgery. As a result, there was a possibility of intestinal, urinary and sexually transmitted diseases. But these 18 patients did not have to undergo chemotherapy, radiation or surgery. Similarly, as a next step, these patients were taken for testing for other diseases. But they did not need any further treatment.

    Cancer patients usually have to undergo difficult treatment. These include surgery, chemotherapy and radiation. Some patients with rectal cancer also need a colostomy bag.

    Experts say the study is the first of its kind in the world to cure all patients. He said the test was effective because not all patients had major problems during the test. In addition, no side effects have been reported from this drug.

    Dostarlimeb is a monoclonal drug that acts as an antibody in the body. Monoclonal antibodies interact with a special protein called PD1 on the surface of cancer cells. This immune system is thought to be effective in identifying and destroying cancer cells.

    In the US, DosterLab 500mg costs around 11,000. Similarly in the UK each dose is available at five thousand 887 pounds.

    Comment Down:

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Related

    Last update

    MUST READ